Editas Medicine, Inc. EDIT · Transcripts

87

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative...

Price2.875

Market Cap399.91 M

Float154.83 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login